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Background
Eagerly awaiting the results of the Management of Mye-
lomeningocele Study (MOMS) with an increasing inter-
est in setting up intrauterine myelomeningocele repair
(IUMR), the optimal management of patients suffering
from congenital myelomeningocele (MMC) has become
a matter of debate again. We performed a cross-sec-
tional study at our referral-center for MMC to compare
the outcomes of our expectantly managed patients with
the results of IUMR and historical controls on which
the MOMS trial has been based on.
Materials and methods
A computed chart review revealed 71 patients suffering
from spina bifida. Of those, 10 have been lost for fol-
low-up and 2 were excluded because they had under-
gone IUMR. A retrospectivea n a l y s i sw a sp e r f o r m e d
only in patients that underwent MMC repair within the
first two days of life and were seen at our outpatient
clinic between 2008 and 2009 f o rar e g u l a ri n t e r d i s c i -
plinary follow-up. Data were collected on: gestational
age (GA) and weight at birth, shunt status at the first
year of live and age at shunt placement, radiological pre-
sence of Arnold-chiari II malformation (ACMII) and
tethered cord (TC), bladder function, lower leg function
and educational level. Data were compared to published
results for IUMR and historical controls [1,2]. Data are
given in percent or mean (standard deviation).
Results
We analyzed the data of 43 patients born with mainly
lumbosacral MMCs between 1979 and 2009 that are
now 13.3 (8.9) years of age. At birth, mean GA was
264.5 (16.3) days and mean weight was 2921.3 (760.3) g,
both significantly than in IUMR patients. 69.8 %
required a shunt placement at a mean age of 16.0 (10.7)
days, which was significantly better than historical con-
trols. In 57.1 % an ACMII and in 41.9% a TC was
observed radiologically. Only two patients underwent a
surgical correction for TC. 69.7% of the patients per-
form clean intermittent catheterization. 56.4% are (assis-
tant) walkers and 64.1% attend regular classes, both
comparable to historical controls.
Conclusions
With a close and interdisciplinary management by
pediatric surgeons, neurologists and urologists, long-
term outcomes of patients suffering from MMC can
currently be considered satisfying. With respect to the
known drawbacks of fetal interventions for mother and
child, especially preterm delivery, the results of the
MOMS trial should be awaited with caution before
jumping on a complex intervention like IUMR.
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